TY - JOUR AU - Lopez-Jaramillo P. AU - Yusoff K. AU - Fuster V. AU - Thrift A. AU - Joshi Rohina AU - Vedanthan R. AU - Yeates K. AU - Mohan S. AU - Trieu K. AU - Johnson Claire AU - Miranda J. AU - Tobe S. AU - Gyamfi J. AU - Kamano J. AU - Ogedegbe O. AU - Ovbiagele B. AU - Bernabe-Ortiz A. AU - Ieremia M. AU - Lazo-Porras M. AU - Owolabi M. AU - Oldenburg B. AU - Praveen Devarsetty AU - Liu P. AU - McCready T. AU - Herasme O. AU - Limbani F. AU - Ponce-Lucero V. AU - Pillay A. AU - Schwalm J. AU - Peiris David AU - Webster Jacqui AB -

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.

AD - Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA. Electronic address: rajesh.vedanthan@mssm.edu.
CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Av. Armendariz 497, Lima 18, Peru.
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.
The George Institute for Global Health, University of Sydney, 50 Bridge Street, Sydney, NSW 2000, Australia.
Research Institute FOSCAL, Bucaramanga, Colombia.
School of Clinical Sciences at Monash Health, Monash University, Wellington Road and Blackburn Road, Clayton, VIC 3800, Australia.
School of Medicine, Queens University, 15 Arch Street, Kingston, ON K7L 3N6, Canada.
School of Medicine, New York University, 550 1st Avenue, New York, NY 10016, USA.
Samoan Ministry of Health, Motootua, Ifiifi street, Apia, Samoa.
College of Health Sciences, School of Medicine, Moi University, PO Box 3900, Eldoret 30100, Kenya.
Centre for Health Policy, School of Public Health, University of the Witwatersrand, 1 Jan Smuts Avenue, Braamfontein, Johannesburg 2000, South Africa.
University of Ottawa, 75 Laurier Avenue East, Ottawa, ON K1N 6N5, Canada.
Population Health Research Institute, 237 Barton Street East, Hamilton, ON L8L 2X2, Canada.
Public Health Foundation of India, Plot No. 47, Sector 44, New Delhi, India.
School of Population and Global Health, University of Melbourne, Parkville, VC 3010, Australia.
Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.
University of Ibadan, Ibadan, Nigeria.
The George Institute for Global Health, 301 ANR Centre, Road No 1, Banjara Hills, Hyderabad 500034, India.
Pacific Research Centre for the Prevention of Obesity and Non-Communicable Diseases, Fiji National University, Suva, Fiji.
University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.
Universiti Teknologi MARA, Selangor and UCSI University, Kuala Lumpur, Malaysia. AN - 27886793 BT - Cardiology Clinics C2 - PMC5131527 C6 - Nihms825276 DP - NLM ET - 2016/11/26 J2 - Cardiology clinics LA - eng LB - AUS
OCS
FP
FY17 M1 - 1 N1 - Vedanthan, Rajesh
Bernabe-Ortiz, Antonio
Herasme, Omarys I
Joshi, Rohina
Lopez-Jaramillo, Patricio
Thrift, Amanda G
Webster, Jacqui
Webster, Ruth
Yeates, Karen
Gyamfi, Joyce
Ieremia, Merina
Johnson, Claire
Kamano, Jemima H
Lazo-Porras, Maria
Limbani, Felix
Liu, Peter
McCready, Tara
Miranda, J Jaime
Mohan, Sailesh
Ogedegbe, Olugbenga
Oldenburg, Brian
Ovbiagele, Bruce
Owolabi, Mayowa
Peiris, David
Ponce-Lucero, Vilarmina
Praveen, Devarsetty
Pillay, Arti
Schwalm, Jon-David
Tobe, Sheldon W
Trieu, Kathy
Yusoff, Khalid
Fuster, Valentin
K01 TW009218/TW/FIC NIH HHS/United States
U01 HL114180/HL/NHLBI NIH HHS/United States
U01 HL114200/HL/NHLBI NIH HHS/United States
U01 NS079179/NS/NINDS NIH HHS/United States
Review
Netherlands
Cardiol Clin. 2017 Feb;35(1):99-115. doi: 10.1016/j.ccl.2016.08.010. N2 -

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.

PY - 2017 SN - 1558-2264 (Electronic)
0733-8651 (Linking) SP - 99 EP - 115 ST - Cardiol. Clin.Cardiol. Clin. T2 - Cardiology Clinics TI - Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries VL - 35 Y2 - FY17 ER -